Literature DB >> 16093452

Endothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II.

Andrea Page1, Heather Reich, Joyce Zhou, Vesta Lai, Daniel C Cattran, James W Scholey, Judith A Miller.   

Abstract

Endothelial function is dependent on the generation of nitric oxide (NO) by the enzyme endothelial NO synthase (eNOS). One functional coding polymorphism of the eNOS gene (G894-->T) is associated with reduced enzyme activity, increased coronary heart disease, and the development of end-stage renal failure. Because gender and renin-angiotensin system activation also play key roles in the development of renal and cardiovascular disease and because NO plays a role in the response to angiotensin II (AngII), it was hypothesized that the eNOS gene G894-->T polymorphism would be a determinant of the systemic and renal vascular response to AngII. Fifty young, healthy, normotensive individuals who were on a controlled sodium and protein diet for 1 wk underwent assessment of BP and renal hemodynamic function at baseline and during AngII infusion (4 ng/kg per min for 45 min). Participants were genotyped for the eNOS gene G894-->T polymorphism and then segregated into groups on the basis of gender and genotype (GG versus GT/TT). Baseline values for renal blood flow, effective renal plasma flow, and GFR were lower in men with the T allele compared with men who were homozygous for the G allele (P = 0.03), but the polymorphism was not associated with renal hemodynamic function in women. The BP responses to AngII were similar in men and women regardless of genotype. Both multivariate linear regression and analysis of covariance (ANCOVA) revealed a relationship between gender and genotype. Men with the GT/TT genotype exhibited a significantly greater decrease in GFR (P = 0.04) in response to AngII than did those with the GG genotype. This association was not observed in women. The eNOS gene G894-->T polymorphism is a determinant of both baseline renal hemodynamic function and the hemodynamic response to AngII in men but not in women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093452     DOI: 10.1681/ASN.2004110905

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  9 in total

1.  Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury.

Authors:  Michael S Forbes; Barbara A Thornhill; Matthew H Park; Robert L Chevalier
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Sex differences in acute ANG II-mediated hemodynamic responses in mice.

Authors:  Markus P Schneider; Paul F Wach; Melissa K Durley; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-23       Impact factor: 3.619

3.  Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Petter Bjornstad; Julie A Lovshin; Yuliya Lytvyn; Genevieve Boulet; Leif E Lovblom; Omar N Alhuzaim; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-02-02       Impact factor: 19.112

4.  Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.

Authors:  Julie A Lovshin; Geneviève Boulet; Yuliya Lytvyn; Leif E Lovblom; Petter Bjornstad; Mohammed A Farooqi; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Zi Cherney
Journal:  JCI Insight       Date:  2018-01-11

5.  Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Julie A Lovshin; Yuliya Lytvyn; Leif E Lovblom; Alexandra Katz; Geneviève Boulet; Petter Bjornstad; Vesta Lai; Leslie Cham; Josephine Tse; Andrej Orszag; Hillary A Keenan; Narinder Paul; Vera Bril; David T Wong; Kylen D McReelis; Michael H Brent; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-12-06       Impact factor: 19.112

6.  Association of angiotensin-converting enzyme and endothelial Nitric Oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population.

Authors:  Feng-Ying Tang; Fu-You Liu; Xiong-Wei Xie
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

Review 7.  Organ systems dependent on nitric oxide and the potential for nitric oxide-targeted therapies in related diseases.

Authors:  Norman K Hollenberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

8.  Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease.

Authors:  Sourabh Chand; Colin D Chue; Nicola C Edwards; James Hodson; Matthew J Simmonds; Alexander Hamilton; Stephen C L Gough; Lorraine Harper; Rick P Steeds; Jonathan N Townend; Charles J Ferro; Richard Borrows
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

9.  Sex-Related Difference in Nitric Oxide Metabolites Levels after Nephroprotectant Supplementation Administration against Cisplatin-Induced Nephrotoxicity in Wistar Rat Model: The Role of Vitamin E, Erythropoietin, or N-Acetylcysteine.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki
Journal:  ISRN Nephrol       Date:  2013-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.